Medical News

RSS

Powerful orthopedic repair compound

Bone Solutions, Inc. of Dallas, TX, announced at a Dow Jones Lifescience Conference that it had successfully tested its magnesium-based orthopedic adhesive technology in multiple studies to prove full biocompatibility for injection into animals and humans, with powerful mechanical properties that gave its unusual strength and performance beyond current orthopedic industry products.

26 Sep 2005

Investing today in the control of the bird flu virus in animals is cheap compared to the costs of a global pandemic that could occur tomorrow

The global strategy for the control of avian influenza in animals remains largely under-funded despite important contributions pledged by some donors, FAO warned today.

26 Sep 2005

85 percent of postmenopausal women do not get enough calcium

An analysis presented today at the 27th Annual Meeting of The American Society for Bone and Mineral Research found that 85 percent of postmenopausal women do not get enough calcium on a daily basis.

26 Sep 2005

Innovative new treatment for moderate to severe heart failure

Cardiologists at Beth Israel Medical Center are currently enrolling patients in an investigational study that is looking at the safety and efficacy of an innovative new treatment for moderate to severe heart failure, in which a unique pacemaker-like device helps strengthen the heart's pumping power

26 Sep 2005

CytRx granted "Fast Track" designation for ALS drug

CytRx Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted "Fast Track" designation for the company's leading drug candidate arimoclomol for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).

26 Sep 2005

Nanogen issued patent relating to biological screening device

Nanogen announced today it was issued Patent No. 6,942,778, "Microstructure Apparatus and Method for Separating Differently Charged Molecules Using an Applied Electric Field" by the U.S. Patent and Trademark Office.

26 Sep 2005

New treatment option for chronic sinusitis

Acclarent on Saturday unveiled their new treatment option for chronic sinusitis, the Balloon Sinuplasty procedure. Results from the initial safety and feasibility study of this unique, catheter-based treatment for chronic sinusitis were presented by William Bolger, MD, FACS.

26 Sep 2005

Tests of cognitive function are the best way so far to predict whether healthy elderly people will develop Alzheimer's

Although Alzheimer's disease begins long before symptoms appear, early diagnosis of Alzheimer's has so far been elusive. And given that there is no cure for the disease, benefits of early detection remain questionable.

26 Sep 2005

Potential oral drug for rheumatoid arthritis

A potential oral drug for rheumatoid arthritis (RA) may encourage women to treat their condition earlier rather than later because it is less arduous than currently available treatments. Early treatment is important because RA most often develops between the ages of 35 and 50 and is two- to three times more prevalent in women.

26 Sep 2005

New method of radiation treatment may improve the local control of breast cancer

A new method of radiation treatment may improve the local control of breast cancer significantly which, is very important to cancer sufferers because it can preserve the breast and may also reduce the spread of the disease.

26 Sep 2005

Microchip system aims to reduce the number of animals used in the development of new drugs

Reducing the number of animals used in the development of new drugs is a priority for the pharmaceutical industry

26 Sep 2005

A new, less toxic way to treat malignant melanoma

A new, less toxic way to treat malignant melanoma (skin cancer) is being developed by medicinal chemists at Reading University. They have produced a range of prodrugs: compounds that offer the potential to be converted to toxic molecules only within the vicinity of tumours. These prodrugs aim to reduce the toxicity of treatment.

26 Sep 2005

Pharmacists can play a vital role in bridging the care gap for patients with cystic fibrosis

Patients with cystic fibrosis typically take large numbers of medicines and are managed by healthcare professionals in both primary and secondary care. Most of patients' regular medication is prescribed by general practitioners, whereas complex and new treatments are initiated and provided through hospital outpatient clinics.

26 Sep 2005

Extreme gene pin-pointed

One teenager likes to snowboard off a cliff. Another prefers to read a book and wouldn't think of trading places. Why these differences exist is a mystery, but for the first time researchers have identified a possible genetic explanation behind risk-seeking behavior.

26 Sep 2005

Mutations in receptor tyrosine kinases provide potential for highly-targeted cancer therapies

Scientists from J. Craig Venter Institute, Ludwig Institute for Cancer Research, and The Johns Hopkins University School of Medicine identified three novel mutations in two receptor tyrosine kinases in glioblastoma tumors using high throughput sequencing.

26 Sep 2005

Parents' Views on School Wellness Practices

A new national survey of parents of school-aged children found a significant gap between what parents believe is happening and what is actually happening in terms of nutrition and physical activity in America's schools.

26 Sep 2005

Clinical trial participants may not be as unrepresentative of general clinical populations as often reported

It is often suggested that the results of clinical trials are affected by the fact that the patients who volunteer for a trial are more likely to take their medication effectively than those in standard care. This supposition is, however, strongly refuted in the results of a new study revealed at the British Pharmaceutical Conference in Manchester.

26 Sep 2005

Pharmacists can drastically reduce patients worries about using steroids

For those people who suffer from eczema, the use of topical corticosteroids is high up on their list of concerns: How should they be used? And are they safe?

26 Sep 2005

New study into the health-related quality of life for human immunodeficiency virus (HIV) patients

Pharmacists in Wales have conducted a new study into the health-related quality of life for human immunodeficiency virus (HIV) patients. The surprising results were revealed at the British Pharmaceutical Conference in Manchester.

26 Sep 2005

Vaccine candidate? Researchers synthesize oligosaccharide from anthrax pathogen

For weeks a white powder caused fear and shock for the American population: a few days after the attacks on September 11th, 2001, four innocent people became the victims of letters that contained the powder - spores of the anthrax pathogen. German researchers have now synthesized a molecule characteristic of anthrax in the laboratory which may be the basis for a new anthrax vaccine.

26 Sep 2005

Medical News

Powerful orthopedic repair compound

Investing today in the control of the bird flu virus in animals is cheap compared to the costs of a global pandemic that could occur tomorrow

85 percent of postmenopausal women do not get enough calcium

Innovative new treatment for moderate to severe heart failure

CytRx granted "Fast Track" designation for ALS drug

Nanogen issued patent relating to biological screening device

New treatment option for chronic sinusitis

Tests of cognitive function are the best way so far to predict whether healthy elderly people will develop Alzheimer's

Potential oral drug for rheumatoid arthritis

New method of radiation treatment may improve the local control of breast cancer

Microchip system aims to reduce the number of animals used in the development of new drugs

A new, less toxic way to treat malignant melanoma

Pharmacists can play a vital role in bridging the care gap for patients with cystic fibrosis

Extreme gene pin-pointed

Mutations in receptor tyrosine kinases provide potential for highly-targeted cancer therapies

Parents' Views on School Wellness Practices

Clinical trial participants may not be as unrepresentative of general clinical populations as often reported

Pharmacists can drastically reduce patients worries about using steroids

New study into the health-related quality of life for human immunodeficiency virus (HIV) patients

Vaccine candidate? Researchers synthesize oligosaccharide from anthrax pathogen

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News